Sridhar Kosaraju
Chief Financial Officer, Penumbra.
Companies
- 10X GenomicsBoard member Sep 11, 2019 to now1
- NEVRO CORPBoard member Sep 2, 2021 to Apr 3, 20252
- PenumbraPresident Feb 3, 2020 to Apr 17, 20203
- PenumbraChief financial officer Sep 17, 2015 to Aug 2, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
10X Genomics TXG68,278 shares5$4.8M at $69.95Jun 8, 2026- NEVRO CORP0 shares6Apr 3, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Granted 8,829 shares of 10X Genomics5
- Jun 3, 2025Granted 15,357 shares of 10X Genomics7
- Apr 3, 2025Returned to company 46,575 shares of NEVRO CORP6
- Dec 31, 2024Granted 4,233 shares of NEVRO CORP8
- Sep 30, 2024Granted 2,817 shares of NEVRO CORP9
- Jun 30, 2024Granted 1,870 shares of NEVRO CORP10
- Jun 11, 2024Granted 8,649 shares of 10X Genomics11
- May 23, 2024Granted 19,169 shares of NEVRO CORP12
- Mar 31, 2024Granted 1,090 shares of NEVRO CORP13
- Dec 31, 2023Granted 731 shares of NEVRO CORP14
- Sep 30, 2023Granted 819 shares of NEVRO CORP15
- Jun 30, 2023Granted 619 shares of NEVRO CORP16
- Jun 14, 2023Granted 1,865 shares of 10X Genomics17
- May 25, 2023Granted 6,754 shares of NEVRO CORP18
- Mar 31, 2023Granted 435 shares of NEVRO CORP19
- Dec 30, 2022Granted 397 shares of NEVRO CORP20
- Sep 30, 2022Granted 337 shares of NEVRO CORP21
- Sep 14, 2022Exercised options 10,000 shares at $11.48 of 10X Genomics22
- Jun 30, 2022Granted 331 shares of NEVRO CORP23
- Jun 15, 2022Granted 2,120 shares of 10X Genomics24
- May 26, 2022Granted 4,155 shares of NEVRO CORP25
- May 16, 2022Exercised options 15,000 shares at $11.48 of 10X Genomics26
- Mar 31, 2022Granted 190 shares of NEVRO CORP27
- Dec 31, 2021Granted 169 shares of NEVRO CORP28
- Dec 30, 2021Sold 1,500 shares at $150.38 of 10X Genomics29
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAR10X Genomics, Board member
- 2SEC EDGARNEVRO CORP, Board member
- 3SEC EDGARPenumbra, President
- 4SEC EDGARPenumbra, Chief financial officer
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 5, 2025
- 8SEC EDGARForm 4 filed Jan 2, 2025
- 9SEC EDGARForm 4 filed Oct 2, 2024
- 10SEC EDGARForm 4 filed Jul 2, 2024
- 11SEC EDGARForm 4 filed Jun 13, 2024
- 12SEC EDGARForm 4 filed May 28, 2024
- 13SEC EDGARForm 4 filed Apr 2, 2024
- 14SEC EDGARForm 4 filed Jan 3, 2024
- 15SEC EDGARForm 4 filed Oct 3, 2023
- 16SEC EDGARForm 4 filed Jul 5, 2023
- 17SEC EDGARForm 4 filed Jun 16, 2023
- 18SEC EDGARForm 4 filed May 30, 2023
- 19SEC EDGARForm 4 filed Apr 4, 2023
- 20SEC EDGARForm 4 filed Jan 4, 2023
- 21SEC EDGARForm 4 filed Oct 4, 2022
- 22SEC EDGARForm 4 filed Sep 16, 2022
- 23SEC EDGARForm 4 filed Jul 5, 2022
- 24SEC EDGARForm 4 filed Jun 17, 2022
- 25SEC EDGARForm 4 filed May 27, 2022
- 26SEC EDGARForm 4 filed May 17, 2022
- 27SEC EDGARForm 4 filed Apr 4, 2022
- 28SEC EDGARForm 4 filed Jan 4, 2022
- 29SEC EDGARForm 4 filed Jan 4, 2022